HK15695A - Solid oral administration forms containing ifosfamide as active agent - Google Patents

Solid oral administration forms containing ifosfamide as active agent

Info

Publication number
HK15695A
HK15695A HK15695A HK15695A HK15695A HK 15695 A HK15695 A HK 15695A HK 15695 A HK15695 A HK 15695A HK 15695 A HK15695 A HK 15695A HK 15695 A HK15695 A HK 15695A
Authority
HK
Hong Kong
Prior art keywords
active agent
oral administration
solid oral
forms containing
administration forms
Prior art date
Application number
HK15695A
Other languages
English (en)
Inventor
Sauerbier Dieter
Engel Joergen Dr
Milsmann Eckhard Dr
Molge Klaus Dr
Isaac Otto Dr
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of HK15695A publication Critical patent/HK15695A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15695A 1990-08-03 1995-02-06 Solid oral administration forms containing ifosfamide as active agent HK15695A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (1)

Publication Number Publication Date
HK15695A true HK15695A (en) 1995-02-10

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15695A HK15695A (en) 1990-08-03 1995-02-06 Solid oral administration forms containing ifosfamide as active agent

Country Status (33)

Country Link
US (1) US5158776A (lv)
EP (1) EP0469440B1 (lv)
JP (2) JP3061898B2 (lv)
KR (1) KR0177170B1 (lv)
CN (1) CN1046851C (lv)
AR (1) AR247484A1 (lv)
AT (1) ATE110261T1 (lv)
AU (2) AU643309B2 (lv)
BG (1) BG60900B1 (lv)
CA (1) CA2048367C (lv)
CZ (1) CZ280475B6 (lv)
DE (2) DE4124481A1 (lv)
DK (1) DK0469440T3 (lv)
EG (1) EG19690A (lv)
ES (1) ES2058999T3 (lv)
FI (1) FI97951C (lv)
HK (1) HK15695A (lv)
HR (1) HRP920575B1 (lv)
HU (1) HU206268B (lv)
IE (1) IE66378B1 (lv)
IL (1) IL99031A (lv)
LT (1) LT3528B (lv)
LV (1) LV10043B (lv)
MC (1) MC2274A1 (lv)
MX (1) MX9100441A (lv)
NO (1) NO178252C (lv)
NZ (1) NZ239222A (lv)
PT (1) PT98532B (lv)
RO (1) RO113611B1 (lv)
SG (1) SG181694G (lv)
SI (1) SI9111342B (lv)
SK (2) SK279740B6 (lv)
ZA (1) ZA916124B (lv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
EP3091974B1 (en) 2014-01-06 2020-04-01 Shield TX (UK) Limited Dosage regimen of ferric trimaltol
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
ATE66609T1 (de) * 1986-07-11 1991-09-15 Asta Pharma Ag Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
HRP920575A2 (en) 1995-04-30
ATE110261T1 (de) 1994-09-15
RO113611B1 (ro) 1998-09-30
AU649184B2 (en) 1994-05-12
CN1046851C (zh) 1999-12-01
IL99031A (en) 1996-09-04
FI913710A0 (fi) 1991-08-02
SI9111342B (sl) 1998-10-31
FI97951C (fi) 1997-03-25
EP0469440A1 (de) 1992-02-05
HU206268B (en) 1992-10-28
BG60900B1 (bg) 1996-06-28
NO178252C (no) 1996-02-21
AU643309B2 (en) 1993-11-11
ZA916124B (en) 1992-04-29
IE66378B1 (en) 1995-12-27
JP3061898B2 (ja) 2000-07-10
CN1058715A (zh) 1992-02-19
DE4124481A1 (de) 1992-02-06
HRP920575B1 (en) 1999-04-30
SI9111342A (sl) 1998-04-30
LT3528B (en) 1995-11-27
ES2058999T3 (es) 1994-11-01
NO913019L (no) 1992-02-04
LV10043A (lv) 1994-05-10
DE59102620D1 (de) 1994-09-29
CS240991A3 (en) 1992-03-18
JP2000229860A (ja) 2000-08-22
DK0469440T3 (da) 1994-11-14
SK279739B6 (sk) 1999-03-12
KR920003963A (ko) 1992-03-27
FI913710A (fi) 1992-02-04
CZ280475B6 (cs) 1996-01-17
CA2048367A1 (en) 1992-02-04
SG181694G (en) 1995-05-12
NO913019D0 (no) 1991-08-02
AU8158991A (en) 1992-02-06
BG94934A (bg) 1993-12-24
CA2048367C (en) 2000-05-23
SK279740B6 (sk) 1999-03-12
MC2274A1 (fr) 1993-06-23
PT98532B (pt) 1999-01-29
IL99031A0 (en) 1992-07-15
NO178252B (no) 1995-11-13
AR247484A1 (es) 1995-01-31
HUT59316A (en) 1992-05-28
EG19690A (en) 1995-09-30
EP0469440B1 (de) 1994-08-24
KR0177170B1 (ko) 1999-03-20
MX9100441A (es) 1992-04-01
IE912774A1 (en) 1992-02-12
HU912594D0 (en) 1992-01-28
JPH04243828A (ja) 1992-08-31
FI97951B (fi) 1996-12-13
NZ239222A (en) 1993-01-27
PT98532A (pt) 1992-06-30
LTIP921A (en) 1995-03-27
US5158776A (en) 1992-10-27
LV10043B (en) 1995-06-20
AU4483693A (en) 1993-11-11
JP3545300B2 (ja) 2004-07-21

Similar Documents

Publication Publication Date Title
PT86000A (en) Pharmaceutically active compounds
IL82924A0 (en) Sustained release pharmaceutical compositions containing katotifen
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
HUT71131A (en) Paramycin formulations for oral administration
HK15695A (en) Solid oral administration forms containing ifosfamide as active agent
EP0294053A3 (en) Physiologically active agent for agricultural use
EP0137234A3 (en) Physiologically active compositions
IL98749A0 (en) Pharmaceutical compositions containing penciclovir
GB2195893B (en) Sustained release pharmaceutical compositions
GB2274273B (en) Medicament pack
ZA882961B (en) Oral compositions comprising anti-calculus agents
IL70771A0 (en) Pharmaceutical compositions containing nafazatrom
GB8802391D0 (en) Medicinal formulations
GB8322115D0 (en) Physiologically active compositions
GB8326753D0 (en) Physiologically active compositions
GB8322826D0 (en) Physiologically active compositions
IE900393L (en) Pharmaceutical compositions for oral administration
GB8715274D0 (en) Pharmaceutically active compounds
GB8719717D0 (en) Pharmaceutically active compounds
GB8725540D0 (en) Pharmaceutically active compounds
GB8708234D0 (en) Pharmaceutically active compounds
GB8805811D0 (en) Pharmaceutically active compounds
ZA878046B (en) Pharmaceutically active compounds
GR3020329T3 (en) Pharmaceutically active compounds
ZA915026B (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100724